Literature DB >> 12970057

Levalbuterol is not more cost-effective than albuterol for COPD.

Leslie Hendeles, Abraham Hartzema.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12970057     DOI： 10.1378/chest.124.3.1176

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  2 in total

1.  Advocating for patients through clinical research.

Authors:  Leslie Hendeles
Journal:  J Pediatr Pharmacol Ther       Date:  2008-01

2.  Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing.

Authors:  John F Freiler; Rajiv Arora; Thomas C Kelley; Larry Hagan; Patrick F Allan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.